Release
📈 Stocks
Mozart Therapeutics Reports Positive Phase 1 Data for MTX-101 in Type 1 Diabetes
(20 minutes ago)
Mozart Therapeutics advances its clinical pipeline with positive Phase 1 and preclinical data for MTX-101, showing therapeutic potential in treating Stage 3…